Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Zynerba Pharmaceuticals Inc (ZYNE-RM)

Moscow
Currency in RUB
Disclaimer
121.00
0.00(0.00%)
Real-time Data

ZYNE-RM Comments

Anybody knows what happened? Premarket highest price was 4,46
Jazz Pharmaceuticals to acquire GW Pharma for $7.2 billion in cash and stock, GW soars 46% premarket. GW and Zyne are competitors
to the moon
im afraid we need to find ground first to jump up... :(
since 3.5 is no longer support (no as solid as i thoght) now 2.55 b4 terra incgnita...
tell me if im wrong. For now we know that zygel has great tolerance and is really effective with 12 months long treatment for epliepsy seizures. But there is plenty of different drugs with similar effectiveness on the market so nothing special no breakethrough. Main goal is to prove that it is effective with Fragile-X syndrom where for now there is no drug on the market and with that we still are hitting wall with zygel. If zyne proves it is statistically effective with 90% methylation – known as full methylation zyne might be the only one firm with such drug so it would be great.  If it fails zyne is done and dead.
buy time..
Easy ppl 3.5 support is solid as titanium :D
I didnt find any news that can cause such dump
Omg
What news did I miss?
 I bet its misty forecast about FX tiral. I mean it will happend but far in futer for some inverstos. On the other hand look at volume. Last time while Zyne presented results of phase 2 with signs of improvement onlyt with ad hoc group the slide was over 50% with huge volume. Now it's aint that bad but investors have to brace for hold till 2022.
🚀🚀🚀🚀
Don't know what is going on but it's so good :D
Why premarket no work？
whats keeping the price of zynerba's stock from increasing? They are FDA approved.. cant figure out
whats your source of fda aapproval?
They are not approved yet. But thry will.
Zyne is a strong competitor.it's a waiting game now
Sure
finally some update from zyne: https://zynerba.com/zynerba-pharmaceuticals-provides-update-on-recent-milestones/
Everything looks fine at the moment.
im also happy about their cooperation with fed, i guess b4 Christmas we will know more if there is a chance to move zygel forward
i hope so, as GW didnt corrupt FDA to block competitors saying something like “it’s soo hard to look at more than one CBD product”:))
gonna reach new lows?
No reason for that. Just waiting for FDA response, it’s worth it.
Sure, im w8ing for aby update but buying more is always on the dip:d
That’s true:)
Missed EPS
recent rise: bull trap or no?
Not sure you should worry about it till we get the fda report
 TBH Im worring myself because they do no make money so its kind of important how they spend it :D
q2 resultat? cant find it
Just still not realised
any1 has any info about further guidance with zygel trials with fx?
Nope, they will announce
thanks!
som q2 resultat? cant find it
Till the end of year will rise sharply. Just patience. FDA approval soon.
Let it be a nice monday...
the only thing that is nice so far are your thumbs up on my comment... so sad :( :D but still thaks.
Any comments
Going to retest March lows? Maybe break down to near 2$ and then reverse?
I think reverse now
It stopped falling and trading sideways. Volume was massive.
Lol market don’t look at the data. Zygel showed good improvements in more than half catagory and that means FDA should approve it. What a good price for shares now!
I think I read Zyne statement carefully and it does not sound as bad as it looks for now.
Look at the history for the past 5 years.  Double spikes at the top then it crashed hard. No triple peaks anywhere on the graph. Im waiting for a new bottom. Not chancing a third spike.
Did u sell?
 No, I did not :)
Now's your chance.
I think these guys are closer than ever to sales start. They have enough cash, so it can grow 10x in a year.
...
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.